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ABSTRACT
To achieve maximal protection against vaccine-preventable diseases, a child should receive all immuniza-
tions within recommended intervals. Clinic records of 512 Nigerian children were evaluated for timeliness 
in receiving vaccines and the completion rates of the schedule. About 30% of the children presented after 
four weeks of age for their first immunization; 18.9-65% of the children were delayed in receiving various 
vaccines compared to the recommended ages for receiving the vaccines. Only 227 (44.3%) children were 
fully immunized. Health education and mass mobilization of the community and health workers are 
recommended to improve the uptake of vaccines and to encourage timely receipt of vaccines.
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INTRODUCTION
The standard measure of vaccination coverage is the 
percentage of children who have received the requi-
site number of vaccine doses irrespective of the age 
at receipt of the vaccine (1). However, to achieve 
maximal protection against vaccine-preventable 
diseases, a child should receive all immunizations 
within recommended intervals (2). Receipt of vac-
cines at recommended ages and intervals ensures 
that the child is adequately protected from target 
diseases at all times. The authors are aware of only 
one study that assessed the timeliness of receipt of 
vaccines in Nigerian children and only on a sample 
of 110 children (3).
Nigeria operates the immunization schedule of the 
Expanded Programme on Immunization which 
prescribes five visits to receive one dose of Bacille 
Calmette Guerin (BCG), four doses of oral polio 
vaccine, three doses of diphtheria, pertussis and 
tetanus vaccine, and one dose of measles vaccine 
(4). In 2004, the country included hepatitis B and 
yellow fever vaccines in its schedule, recommend-
ing the receipt of three doses of hepatitis B at birth, 
at six weeks of age, and at 14 weeks of age while 
yellow fever should be given at nine months of 
age, along with measles vaccine (5). Previous assess-
ments of full immunization did not include hepati-
tis B and yellow fever (6,7).
This study evaluated the timeliness of receipt of 
immunization among children attending the 
immunization clinic of the Institute of Child 
Health, University of Benin, Benin city, Nigeria. 
MATERIALS AND METHODS
The Institute of Child Health immunization clinic 
offers services to inhabitants of Benin city, the capi-
tal of Edo state in mid-western Nigeria. The services 
offered include immunization, growth monitoring, 
nutrition education, and general health education. 
Immunizations are offered everyday, except for 
BCG and measles, which are offered only on Fri-
days. Every child who commences immunization 
in this facility has a record of his/her biodata and 
the date of receipt of various vaccines. About 1,000 
children per year receive their immunizations in 
this facility. The immunization services offered 
were evaluated in terms of the timeliness of receipt 
of vaccines, the immunization rates for individu-
al vaccines, including the recent additions to the 
schedule, and the completion rates of the infant 
immunization schedules
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received their routine immunizations at the facility 
during September 2004–March 2005. Data on date 
of birth, age at commencement of immunization, 
place of birth, age of mother, age of father, and the 
date of receipt of various vaccines were retrieved 
from the clinic records of these children. Age at re-
ceipt of immunization was calculated in days using 
the dates of birth and the dates of receipt of vac-
cines. At the time of review of data (March 2007), 
the youngest child was aged at least 24 months. 
The number of visits made was also recorded. The 
uptake of vaccines was recorded as simple percent-
ages. 
The timeliness of receipt of a vaccine is determined 
by the recommended age for receipt of the given 
vaccine. Previous studies on timeliness, involving 
schedules recommending receipt of vaccines at spe-
cific dates, have allowed 14, 28, and 30 days of the 
grace period (2,3,7). In this study, four timeframes 
were used for evaluating the timeliness of receipt of 
three doses of oral polio vaccine (OPV1, OPV2, and 
OPV3), three doses of diphtheria, pertussis and teta-
nus vaccine (DPT1, DPT2, and DPT3), and three 
doses of hepatitis B vaccine (HepB birth, HepB2, 
and HepB3) as follows: (a) too early if the vaccine 
was received earlier than the recommended age; 
(b) being on time if the vaccine was received on or   
before  two weeks after the due date; (c) acceptably 
early if received between two and  four weeks after 
the due date, and (d) delayed if received after four 
weeks of the due date.
Full immunization was defined as receipt of BCG, 
three doses of OPV, three doses of DPT, three doses 
of hepatitis B vaccine, and a dose each of measles 
and yellow fever vaccines respectively.
Drop-out rate was calculated as the difference in 
percentage coverage in between the consecutive 
vaccines.
RESULTS
There were 265 male and 246 female children. The 
sex of one child was not recorded. The mean age 
of the mothers was 28.35±5.14 (range 16-45) years 
while that of fathers was 35.4±7.05 (range of 19-80) 
years.
Table 1 shows the uptake of various vaccines. The 
uptake was the highest for BCG, OPV0, and HepB 
birth at 89.5%, 96.7%, and 93.8% respectively 
while it was the lowest for measles and yellow 
fever vaccines at 57.6% and 57.2% respectively. 
The uptake of HepB2 and HepB3 was 84.4% and 
63.7% respectively. Compared to the uptake of 
DPT2 (81.1%) and DPT3 (69.5%) which should be 
received at the same ages, the difference was not 
significant (p<0.05). The full immunization status 
was achieved in 227 (44.3%) children. 
Table 1 also shows the mean ages at receipt of differ-
ent vaccines compared to the recommended ages. 
The difference between the mean ages at receipt 
and the recommended ages ranged from 17.4 days 
Table 1. Uptake of vaccines and comparison of mean age at receipt of vaccines with  recommended 




Age (days) at receipt Difference*
(days)
p value
No. % Mean Mode Median
BCG 452 88.3 0 27.9 10 18 27.9 0.0001
OPV0 493 96.3 0 27.5 10 17 27.5 0.0001
HepB B 480 93.8 0 44.0 43 43 44.0 0.0001
OPV1 449 87.7 42 66.1 43 43 24.1 0.0001
OPT1 460 89.8 42 59.3 43 47 17.3 0.0001
HepB2 432 84.4 42 83.6 71 75 41.6 0.0001
OPV2 400 78.1 70 100.3 71 86 30.3 0.0001
DPT2 416 81.1 70 92.3 71 80 22.3 0.0001
OPV3 305 59.6 98 133.9 99 117 35.9 0.0001
DPT3 356 69.5 98 126.8 99 112 28.8 0.0001
HepB3 326 63.7 98 143.9 134 124 45.9 0.0001
MEAS 295 57.6 270 287.4 271 280 17.4 0.0001
YF 293 57.4 270 287.8 271 280 17.8 0.0001
*The difference between age at receipt of vaccines and recommended age for vaccine; HepB B= 
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for measles to 45.9 days for HepB3. The deviation 
from the recommended ages was highly significant 
for all the vaccines (p=0.0001). There was increas-
ing drop-out between consecutive vaccines, 7.2% 
between BCG and DPT 1, and 19.3% between DPT1 
and DPT3. Between HepB birth and HepB3, the 
drop-out rate was 30.1% and 11.7% between DPT 
3 and measles vaccine. The drop-out rate between 
OPV0 and measles vaccine was 38.7%. [OPV0 was 
used here rather than the standard BCG because 
it had the highest coverage of the three vaccines 
given at first contact]. 
Table 2 shows the age distribution at receipt of the 
vaccines recommended at birth. Less than 50% of 
tively. Some (n=20; 6.8%) children received measles 
vaccine before the age of nine months while the 
date of receipt was not recorded for five children 
who had received measles vaccine, and they were, 
therefore, excluded from this analysis.
The age at commencement of immunization was 
significantly associated with the immunization sta-
tus. Of those who commenced immunization after 
the age of 28 days, 99 (66.9%) did not complete 
their immunization compared to 186 (51.1%) of 
those commencing before 28 days. Commence-
ment of immunization at an age above 28 days was, 
thus, associated with a higher chance of non-com-
pletion of the immunization schedule (p=0.01). 
Table 2. Age distribution of 512 children at receipt of BCG, OPV0, and HepB birth
Age (days) at 
receipt 
BCG OPV0 HepB birth
No. % No. % No. %
≤14 208 42.2 170 37.6 92 19.2
15-28 131 26.6 142 31.4 68 14.2
≥29 154 31.2 140 31.0 320 66.6
the children received the doses of vaccines to be 
received at birth within the first two weeks of life. 
Table 3 shows the timeliness of receipt of the vari-
Table 3. Timeliness of receipt of vaccines among 512 children attending a clinic-based 
               immunization service
Vaccine
Timeliness of receipt of immunization
Too early On time Acceptably early Delayed
No. % No. % No. % No. %
OPV1 30 6.7 232 51.7 49 10.9 138 30.7
DPT1 37 8.1 283 61.5 53 11.6 87 18.9
HepB2 12 2.8 94 21.8 45 10.4 281 65.0
OPV2 16 3.8 175 43.8 69 16.0 146 36.4
DPT2 24 5.8 215 51.8 69 16.6 107 25.8
OPV3 12 3.9 118 38.7 68 19.0 117 38.4
DPT3 16 4.5 166 46.7 71 19.9 103 28.9
HepB3 18 5.5 61 18.7 39 12.0 208 63.8
ous vaccines; 18.7-61.5% of the children received 
various vaccines on time while 18.9-65% were de-
layed in receipt of the various vaccines. Children 
were more likely to receive DPT1 on time while 
more children were delayed for receipt of hepatitis 
B vaccines, with 65% being delayed for receipt of 
HepB2 and 63.8% for HepB3. 
The large majority (n=213; 73.2%) of the children 
received their measles vaccine at nine months of 
age while 33 (11.3%), 14 (4.8%), and 6 (2.1%) 
received it at 10, 11, and 12 months or later respec-
Age of mother and father and place of birth were 
not significant as determinants of completion of 
the immunization schedule.
DISCUSSION
The uptake of vaccines for the study population 
was higher than for the national figures (5). The 
uptake of earlier vaccines in the schedule was high-
er than for latter vaccines. This was consistent with 
findings of other studies (8-10). However, the fact 
that none of the vaccines received at first contact 
was 100% may indicate the presence of missed op-
portunities. It was also observed that the uptake 
of the three vaccines at first contact was different. 
This was probably due to non-administration of si-Sadoh AE et al. Timeliness of immunization in Nigerian children
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multaneous vaccines with the rescheduling of BCG 
which is given only on Fridays.
The uptake of hepatitis B vaccine was not signifi-
cantly different from that of DPT which suggests 
that, as a new vaccine, its performance was ade-
quate. However, the target as defined in the first 
EPI regional strategic plan for 2001-2005 for the Af-
rican region of HepB3 coverage being equal to that 
of DPT3 was not met (11). The target of 80% cover-
age for DPT3 was also not met (11). High drop-out 
between DPT1 and DPT3 and between HepB birth 
and HepB3 may be responsible for this. It was ob-
served that there was a tendency of delay in receipt 
of hepatitis B vaccine doses. Late presentation for 
immunization among the study population neces-
sitated the synchronization of the second dose of 
hepatitis B vaccine with the second dose of DPT, 
resulting in separate appointments for DPT3 and 
HepB3. These separate appointments may have re-
sulted in increased drop-out for HepB3 which was 
scheduled later. Non-administration of simultane-
ous injections was also a contributory factor to de-
lay in receipt of hepatitis B vaccine doses and may 
also have contributed to higher drop-out. 
There was a steady increase in drop-out between 
consecutive vaccines, with drop-out being the high-
est between DPT3 and measles vaccine. This find-
ing has been previously documented (7,12). The 
suggested explanation included the longer interval 
between DPT3 and measles vaccine (three and a 
half months) compared to that between the earlier 
vaccines in the schedule (four weeks). It is also sug-
gested that, as the number of weeks/months post-
partum increase, mothers begin to be engaged in 
other activities such that they may forget and/or 
may not have time to make scheduled visits for im-
munizations.
The full immunization rate for the children attend-
ing the study facility was only 44.3%. This is low 
compared to the findings of another clinic-based 
study from Benin, in which 72.4% of infants stud-
ied had completed the immunization schedule (7). 
The difference may stem from the fact that immu-
nization is free for this study population whereas 
mothers had to pay for consumables in the other 
clinic which is also privately-owned. These other 
mothers may, thus, be more motivated. The other 
study evaluated children during their visit for the 
last vaccine in the series. This would have excluded 
children who defaulted completely at earlier ages, 
giving an erroneous picture of a higher completion 
rate for the schedule. Also, the inclusion of hepati-
tis B and yellow fever vaccines in the definition 
of full immunization may have contributed to the 
lower rate in this study as this is a more stringent 
criterion. 
From this study, it is observed that children present-
ed late for immunization, with over 30% presenting 
after four weeks of life. This late presentation con-
tributed to delay in receipt of the earlier vaccines in 
the schedule. The age at presentation was also a sig-
nificant determinant of completion of the sched-
ule. Children who presented early were more likely 
to complete the immunization schedule compared 
to those who presented late. This finding has previ-
ously been reported (13). The reasons for the delay 
in commencing immunization were not explored 
in this study.
For the vaccines administered at birth, less than 
50% of the children presented within the first two 
weeks of life. The birth doses of vaccines are to pre-
vent perinatal or early neonatal transmission; thus, 
the late presentation of children for these doses 
would place them at a risk of contracting the tar-
get diseases before receipt of the requisite immu-
nization. This is particularly critical for hepatitis B 
immunization for which its efficacy in preventing 
perinatal transmission is dependent on the admin-
istration of the vaccine within 24 hours of birth 
(14).
The immunization schedule defines minimal age 
for receipt of vaccines. In this study, 57-75% of 
the children received various vaccines on time or 
acceptably early, except for HepB2 and HepB3 for 
which the corresponding values were 32.4% and 
30.7% respectively. This means that a significant 
proportion of the children did not receive their 
vaccines on time or early enough, thus leaving 
them unprotected or inadequately protected for 
varying periods of time. In the Nigerian study that 
examined age-appropriate vaccinations, only 26% 
of surveyed children received all their vaccines 
within the recommended period (3). Also in the 
United States, approximately 74% of children were 
delayed for one or more vaccinations during the 
first 24 months of life (1). 
The implication of delay in receipt of vaccines is 
that a pool of children with incomplete or no im-
munization may build up (albeit temporarily). The 
presence of such a pool of susceptibles may pre-
dispose to the spread of an epidemic. While the 
specific reasons for the delay in receipt of vaccines 
were not explored, it is possible that the delay in 
commencing immunizations, as earlier explained, 
was a contributing factor. This explanation seems 
tenable against the backdrop that most delays were 
for earlier vaccines in the schedule.
Almost three-fourths of those who received mea-
sles vaccine did so in the ninth month of life. The 
timely  receipt  of  this  vaccine  may  be  because  it Sadoh AE et al. Timeliness of immunization in Nigerian children
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is the last vaccine in the immunization schedule, 
and mothers are more likely to remember this. It 
may also be a reflection of the commitment of this 
group of mothers who presented for the last vac-
cine of the schedule, especially when considered 
against high drop-out between OPV0, one of the 
first vaccines in the schedule, and the measles vac-
cine, the last one in the schedule. The uptake for 
this vaccine is, however, low, with just over 50% of 
the study population receiving it.
The study had a few limitations. There was no track-
ing of the children to determine if they had moved 
out of the city or if they had completed their im-
munizations with a different provider. The data 
were also not checked against the immunization 
cards of the children to verify the completeness 
and accuracy of the records.
Based on the findings of the study, the following 
recommendations are made:
Health education and mass mobilization of the 
community served by this clinic are urgently need-
ed not only to increase the uptake but also for the 
timely receipt of vaccines. Early commencement 
of immunization and completion of the sched-
ule should be emphasized. Health workers would 
need to be trained to implement the practice of 
administering birth doses of hepatitis B vaccine, 
OPV, and BCG while strategies to reach babies born 
outside health facilities with doses of vaccines at 
birth should be explored. This is especially so given 
the current impetus to eradicate poliomyelitis and 
the fact that hepatitis B vaccine needs to be given 
within 24 hours of birth for it to be effective in 
preventing perinatal transimission. This clinic 
should incorporate regular evaluations of its prac-
tice to enable it to improve its effectiveness. Finally, 
a community-based evaluation of immunization is 
required to further elucidate the factors affecting 
the uptake of vaccines, including the age at presen-
tation for vaccinations.
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